SARS News and Research

RSS

Sobering statistics from the AHA's 2023 heart disease and stroke update

The AHA discusses some of the ways in which COVID-19 impacted cardiovascular health throughout the pandemic.

25 Jan 2023

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Researchers discuss the efficacy of the bivalent COVID-19 vaccine against symptomatic infection with SARS-CoV-2 variants.

25 Jan 2023

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

According to the World Health Organization, each year there are an estimated 1 billion cases of influenza, between 3-5 million severe cases and up to 650,000 influenza-related respiratory deaths globally.

25 Jan 2023

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.

25 Jan 2023

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

The potential "tripledemic" of influenza, SARS-CoV-2 and RSV (respiratory syncytial virus) infection continues to be a concern.

25 Jan 2023

FDA briefing discusses different COVID-19 vaccination regimens

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory committee meeting scheduled for January 26, 2023, the national agency proposed that people should be given yearly coronavirus disease 2019 (COVID-19) vaccines.

25 Jan 2023

Data demonstrates SARS-CoV-2 Omicron XBB.1.5 substantially escapes NAb responses after bivalent mRNA boosting

Researchers reported that the SARS-CoV-2 Omicron XBB.1.5 variant evades neutralizing response elicited by bivalent vaccine boosters.

25 Jan 2023

Expert panel proposes stringent biosecurity oversight to avert future pandemics

The National Science Advisory Board for Biosecurity (NSABB) issued draft recommendations to the National Institutes of Health (NIH) on January 20, 2023, on the effectiveness of two biosecurity policy frameworks existent in the United States (US).

25 Jan 2023

Maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy

Researchers assessed the impact of SARS-CoV-2 vaccination on pregnant women during the Omicron wave.

25 Jan 2023

Study suggests cortical hemorrhage in fetal brain may be associated with COVID-19

Researchers evaluated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on fetal brain health.

25 Jan 2023

Cryo-electron microscopy reveals detailed blueprint of viral genome replication machinery

RNA viruses, such as the coronavirus that causes COVID-19, are in a life-and-death race the moment they infect a cell.

25 Jan 2023

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

In a recent study posted to medRxiv*, researchers in Denmark examined the risk of adverse events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-based bivalent booster vaccination.

24 Jan 2023

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

A recent PNAS journal study has sought to address the above-stated drawback and developed a new strategy that involves a self-assembling scaffold of proliferating cell nuclear antigen (PCNA). This technique can develop nanoparticles containing evenly incorporated heterotypic antigens.

24 Jan 2023

Understanding endemic and novel zoonotic spillovers from rodent trapping studies

The global impact of novel zoonotic pathogen spillovers has been highlighted through the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the rapid outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. In the past, similar effects were recorded during the HIV/AIDs and Spanish Influenza pandemics.

24 Jan 2023

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.

24 Jan 2023

Wastewater-based epidemiology for COVID-19 monitoring and public health protection at three UK airports

Researchers performed SARS-CoV-2 surveillance in UK airports using wastewater monitoring.

24 Jan 2023

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine

Researchers described reasons cited by adults for receiving or not receiving COVID-19 booster vaccines.

24 Jan 2023

Transcriptomic analysis of placental tissue aids in understanding the pathogenic mechanisms of SARS-CoV-2 in pregnancy at the cellular level

Researchers explored the pathogenic mechanisms of SARS-CoV-2 in pregnancy using digital spatial profiling of placental tissue.

24 Jan 2023

Researchers identify a key host-cell player in COVID-19 infections

Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.

24 Jan 2023

Researchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccine

Researchers assessed the effectiveness of pan-sarbecovirus-neutralizing antibodies against SARS-CoV-2.

24 Jan 2023

SARS News and Research

Sobering statistics from the AHA's 2023 heart disease and stroke update

Updated bivalent mRNA booster protects against circulating SARS-CoV-2 variants

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

FDA briefing discusses different COVID-19 vaccination regimens

Data demonstrates SARS-CoV-2 Omicron XBB.1.5 substantially escapes NAb responses after bivalent mRNA boosting

Expert panel proposes stringent biosecurity oversight to avert future pandemics

Maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy

Study suggests cortical hemorrhage in fetal brain may be associated with COVID-19

Cryo-electron microscopy reveals detailed blueprint of viral genome replication machinery

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

Mosaic RBD nanoparticles offer 100% protection against SARS-CoV-2 in animal model

Understanding endemic and novel zoonotic spillovers from rodent trapping studies

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Wastewater-based epidemiology for COVID-19 monitoring and public health protection at three UK airports

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine

Transcriptomic analysis of placental tissue aids in understanding the pathogenic mechanisms of SARS-CoV-2 in pregnancy at the cellular level

Researchers identify a key host-cell player in COVID-19 infections

Researchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccine

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News